SCHEMBL30774866

SCHEMBL30774866

N#Cc1ccc(-c2cncc3c2OCCN3C(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.47
▸ EIF4A3 P38919 2/20 0.45
▸ KDM1A O60341 1/20 0.40
▸ SLC22A12 Q96S37 3/20 0.40
▸ EGLN1 Q9GZT9 1/20 0.40
▸ HCRTR2 O43614 1/20 0.39
▸ MKNK1 Q9BUB5 3/20 0.38
▸ MKNK2 Q9HBH9 3/20 0.38
▸ EIF4E P06730 1/20 0.38
▸ SLC6A7 Q99884 1/20 0.37
▸ FNTA P49354 1/20 0.37
▸ FNTB P49356 1/20 0.37
▸ PGGT1B P53609 1/20 0.37
▸ SLC22A6 Q4U2R8 1/20 0.36
▸ SLC22A8 Q8TCC7 1/20 0.36
▸ UCHL1 P09936 1/20 0.36
▸ USP30 Q70CQ3 1/20 0.36
▸ PHGDH O43175 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30774812 0.90 CYP11B2 (0.42) KDM1ASLC22A12EGLN1MKNK1MKNK2
SCHEMBL30774926 0.89 KCNH2 (0.43) POLBSLC22A12EGLN1FNTAFNTB
SCHEMBL30774573 0.87 CYP11B2 (0.44) SLC22A12EGLN1
SCHEMBL30773968 0.87 KDM1A (0.44) KDM1ASLC22A12EGLN1MKNK1MKNK2
SCHEMBL30774887 0.87 SLC6A9 (0.39) KDM1ASLC22A12EGLN1MKNK1MKNK2
SCHEMBL30774506 0.86 STAT3 (0.44) POLBKDM1ASLC22A12EGLN1FNTA
SCHEMBL30773965 0.85 FAAH (0.40) EIF4A3SLC22A12FNTAFNTB
SCHEMBL30774868 0.84 NAAA (0.43) EIF4A3SLC22A12
SCHEMBL30774875 0.82 SLC22A12 (0.39) SLC22A12EGLN1UCHL1USP30
SCHEMBL30774475 0.82 USP30 (0.46) EIF4A3KDM1ASLC22A12UCHL1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US disclosed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP disclosed
WO-2024061371-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 广州威诺森医药科技有限公司 2024-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof STS, NR5A1, CYP21A2 POLB 2549/4885EIF4A3 1499/4885KDM1A 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback